Can you show the Investigator Global Assessment (IGA) grading system?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

IGA Grading System for Acne Vulgaris

The Investigator Global Assessment (IGA) for acne is a 5-point ordinal scale ranging from 0-4 (clear, almost clear, mild, moderate, and severe) that represents the consensus standard for quantifying acne severity in clinical practice and trials in the United States. 1

The Scale Structure

The IGA uses the following severity categories:

  • Grade 0: Clear
  • Grade 1: Almost Clear
  • Grade 2: Mild
  • Grade 3: Moderate
  • Grade 4: Severe

This framework was established through consensus between stakeholders from the International Dermatology Outcomes Measures and the American Academy of Dermatology 1.

Clinical Context and Usage

The IGA is the most commonly used acne grading system in the United States and demonstrates good agreement between clinician and patient ratings. 1 It has been extensively utilized in randomized controlled trials for acne treatments and serves as the foundation for establishing standardized acne severity assessment 1.

Key Characteristics

The IGA scale:

  • Provides a static, cross-sectional assessment of global disease severity
  • Has been validated across multiple studies showing excellent inter-rater reliability
  • Correlates well with other acne grading systems including the Global Acne Grading System and Comprehensive Acne Severity Scale 1

Important Caveats

The specific descriptors for each grade (0-4) remain to be fully standardized and validated for both facial and truncal acne. 1 The definition of IGA scales has varied over time across different clinical trials, which necessitates ongoing harmonization efforts to facilitate consistent use and enable future meta-analyses 1.

Optimal Grading System Features

An ideal acne grading system should measure:

  • Types of primary acne lesions (comedones, papules, pustules, nodules)
  • Number of lesions
  • Extent and region of skin involvement
  • Strong psychometric properties
  • Ability to categorize severity via descriptive text or photographs
  • Ease of use and stakeholder acceptance 1

The IGA framework addresses these requirements while maintaining practical utility in both clinical trials and routine practice settings.

References

1
Guideline

guidelines of care for the management of acne vulgaris.

Journal of the American Academy of Dermatology, 2024

Related Questions

How should the severity of acne be assessed?
How can I explain to a patient why central sleep apnea is more prevalent at high altitude?
How should pulmonary function tests (spirometry) be interpreted in an 11‑year‑old child according to the GINA 2026 guidelines?
How should I manage a patient with medullary calcinosis and hypertension who has normal kidney function?
What LDL‑cholesterol target and high‑intensity statin regimen should be used to reduce the risk of recurrent ischemic stroke?
How should I explain hyperventilation to a patient at high altitude, including its impact on oxygen and carbon dioxide levels and the risk of central sleep apnea?
What is the pathogenesis, typical clinical manifestations, and characteristic nail findings of psoriasis in a 44-year-old white woman with a 2-year history of the disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.